Ithaca New York based CyteQuest is raising $1,153,125.00 in New Equity Investment.
Ithaca, NY – According to filings with the U.S. Securities and Exchange Commission, CyteQuest is raising $1,153,125.00 in new funding. Sources indicate as part of senior management President, Thomas Corso played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About CyteQuest
High-throughput electroporation with single cell sensitivity. Applications: Gene Therapy, Cas9 RNP Electroporation, Cell-based assays, and Protein Production. System Features: Efficient for difficult to transfect cells, High-throughput, Reproducible single cell environment, Feedback controlled flow, and Sterile processing.
To learn more about CyteQuest, visit http://cytequest.com/
Contact:
Thomas Corso, President
607-216-3012
SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved